TLDRocket
Sign in

Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

+ Follow this topic

Key players

OpenAI Anthropic Co-Scientist Co-Scientist Google DeepMind Isomorphic Labs

Wednesday, 9 September 2026

Insilico's co-CEO hopes 'we might have a chance to stop biological aging' after promising results from its fibrosis drug trial

Fortune 27 ● 3 sources

Insilico Medicine’s co-CEO Feng Ren said early results from its experimental fibrosis drug trial suggest biology-linked aging could slow. The company reported that patients’ predicted biological age declined by roughly 3 years on average, and up to 6 years on one measure. That supports an AI drug-discovery push toward extending healthspan and potentially making aging-related outcomes easier to target.

Read the full story
AI Adoption Healthcare AI Drug Discovery

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.